NIIN Output Data
NIIN:
NSN:
Item Name:
DOXORUBICIN HYDROCHLORIDE FOR IN
Definition:
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| NDC55390-0231-10 | 1VZL6 | A | 5 | 2 | 4 | ZZ | ||
| NDC00013-1086-91 | 58750 | A | 3 | 2 | 4 | KX | ||
| NDC53905-0231-10 | 1CR22 | A | 5 | 2 | 4 | ZZ | ||
| ADRIAMYCIN RDF | 58750 | A | 5 | 1 | 4 | KX | BGDVL |
CAGE Information
| Code | Company |
|---|---|
| 1CR22 | NOVARTIS VACCINES AND DIAGNOSTICS IN |
| 1VZL6 | FALCON PHARMACEUTICALS LTD |
| 58750 | ERBAMONT INC ADRIA LABORATORIES DIV |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| AJCN | PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| ZZZT | NONDEFINITIVE SPEC/STD DATA | 1 SIZE |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.000 MG DOXORUBICIN HYDROCHLORIDE PER ML ACTIVE INGREDIENT WHEN RECONSTITUTED TO 10 ML |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLIGRAMS |
| AGXW | PHYSICAL FORM | FREEZE-DRIED POWDER |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP 10MG VIAL 10S PG |
| FEAT | SPECIAL FEATURES | W/5.000 MG LACTOSE,USP IN EA ML; NOTE: D |
| ZZZK | SPECIFICATION/STANDARD DATA | 81349-MIL-D-37656 GOVERNMENT SPECIFICATION |